Ignite Creation Date:
2024-07-17 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470672
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-18
Brief Title:
Study of SHR-A1921 Combined Adebrelimab in HR-positive HER2-negative Advanced Breast Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Breast Cancer |
| Hormone-receptor-positive Breast Cancer |
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |
Keywords: